4.7 Meeting Abstract

Novel Dual Glucagon and Glucagon-Like Peptide-1 Receptor Agonist LY3305677 Improves Glucose Control, Reduces Body Weight, and Increases Energy Expenditure in Mice

Journal

DIABETES
Volume 70, Issue -, Pages -

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/db21-682-P

Keywords

-

Funding

  1. Eli Lilly and Company

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available